{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:42:04Z","timestamp":1792114924726,"version":"4.4.0"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec><jats:label\/><jats:p>We describe an outbreak of mucormycosis in a pediatric oncology hospital during December 2010 and the measures taken to stop it. The outbreak began with two consecutive cases of laboratory\u2010documented mucormycosis infections within 1 week. Investigations to track the source were conducted immediately. Air plate cultures from machines and ducts supplying patients\u2019 rooms revealed the growth of <jats:italic>Rhizomucor<\/jats:italic>. Of five affected patients, all had acute leukemia and three were histopathologically proven. All patients were treated with liposomal amphotericin B after mucormycosis was diagnosed. Posaconazole was used as a secondary prophylaxis in one case. Three patients died. Pediatr Blood Cancer \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.25673","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T15:08:00Z","timestamp":1437664080000},"page":"171-173","source":"Crossref","is-referenced-by-count":17,"title":["Investigation and Management of a Rhizomucor Outbreak in a Pediatric Cancer Hospital in Egypt"],"prefix":"10.1002","volume":"63","author":[{"given":"Hadir A.","family":"El\u2010Mahallawy","sequence":"first","affiliation":[{"name":"Department of Clinical Pathology, National Cancer Institute Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Khedr","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, National Cancer Institute Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Taha","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology Children Cancer Hospital Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobna","family":"Shalaby","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, National Cancer Institute Cairo University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Department of Infection Control Children Cancer Hospital Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycres.2007.03.004"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.06.003"},{"key":"e_1_2_6_4_1","first-page":"3","article-title":"Mucormycosis in hematologic patients: A review","volume":"2","author":"Garcia\u2010Romero MT","year":"2011","journal-title":"N Dermatol Online"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.13.78"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/599105"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq147"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)05059-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2008.05.017"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.669502"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02982.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1509.090334"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02988.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03456.x"},{"key":"e_1_2_6_15_1","unstructured":"HerbrechtR TissotF AgrawalS PaganoL PettrikosG ViscoliC SkiadaA Lass\u2010Fl\u00f6rlC CalandraT. Update of the ECIL guidelines for antifungal therapy in leukemia and HSCT patients (ECIL\u20105).2013.http:\/\/www.kobe.fr\/ecil\/telechargements2013\/ECIL5%20Antifungal%20Therapy.pdf; accessed 07\/06\/2015."}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25673","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.25673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:29:24Z","timestamp":1695760164000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.25673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1002\/pbc.25673"],"URL":"https:\/\/doi.org\/10.1002\/pbc.25673","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}